Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia
Clinical trial NCT02221505 · TERMINATED
Trial details
- NCT number
- NCT02221505
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.